Abstract
Oxidants participate in lymphocyte activation and function. We previously demonstrated that eliminating the activity of NADPH oxidase 2 (NOX2) significantly impaired the effectiveness of autoreactive CD8+ CTLs. However, the molecular mechanisms impacting CD8+ T cell function remain unknown. In the present study, we examined the role of NOX2 in both NOD mouse and human CD8+ T cell function. Genetic ablation or chemical inhibition of NOX2 in CD8+ T cells significantly suppressed activation-induced expression of the transcription factor T-bet, the master transcription factor of the Tc1 cell lineage, and T-bet target effector genes such as IFN-γ and granzyme B. Inhibition of NOX2 in both human and mouse CD8+ T cells prevented target cell lysis. We identified that superoxide generated by NOX2 must be converted into hydrogen peroxide to transduce the redox signal in CD8+ T cells. Furthermore, we show that NOX2-generated oxidants deactivate the tumor suppressor complex leading to activation of RheB and subsequently mTOR complex 1. These results indicate that NOX2 plays a nonredundant role in TCR-mediated CD8+ T cell effector function.
Cite
CITATION STYLE
Chen, J., Liu, C., Chernatynskaya, A. V., Newby, B., Brusko, T. M., Xu, Y., … Mathews, C. E. (2024). NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function. The Journal of Immunology, 212(2), 258–270. https://doi.org/10.4049/jimmunol.2200691
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.